Published By U.S. Department of Health & Human Services
Issued about 9 years ago
US
beta
Summary
Description
Clinical guidelines recommend that women with hormone-receptor positive breast cancer receive endocrine therapy (selective estrogen receptor modulators or aromatase inhibitors) for five years following diagnosis.